First Patient Dosed in the Phase I/II Study of Umecrine Mood’s Candidate Drug for Premenstrual Dysphoric Disorder
5/23/2013 10:00:39 AM
More...
|
Spring Bank Pharmaceuticals, Inc. Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
5/23/2013 9:55:17 AM
More...
|
Virobay Inc. Initiates a Phase 1 Trial of VBY-036, a Compound Intended for the Treatment of Neuropathic Pain
5/23/2013 9:53:51 AM
More...
|
Promedior Presents Encouraging Results From Clinical Study of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis
5/23/2013 8:43:04 AM
More...
|
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
5/22/2013 10:13:33 AM
More...
|
Protalex, Inc. (PRTX) Reports Positive Interim Review of Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis by Independent Data Safety Monitoring Committee
5/22/2013 10:06:51 AM
More...
|
Addex Therapeutics (ADXN.SW) Validates Potential Efficacy Biomarker for Phase 1 Trial of Its GABA-B Positive Allosteric Modulator, ADX71441
5/21/2013 11:13:51 AM
More...
|
CytRx Corporation (CYTR) Announces Initial Results From Pharmacokinetics Clinical Trial With Aldoxorubicin in Solid Tumors
5/21/2013 9:56:50 AM
More...
|
NeuroSigma, Inc. Release: Positive Results Reported for Phase I Clinical Trial at University of California, Los Angeles (UCLA) for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
5/21/2013 9:55:08 AM
More...
|
Medivir AB (MVIRb.F) Release: Positive Results From a Phase Ia Study With MIV-711 for the Treatment of Skeletal Disorders
5/21/2013 9:29:19 AM
More...
|
ChemoCentryx, Inc. (CCXI) Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor
5/21/2013 9:25:06 AM
More...
|
R-Tech Ueno: Start of the Patient Enrollment of a Phase I/II Clinical Study of Recombinant Human Serum Albumin-Containing Ophthalmic Solution (Development Code: RU-101) in U.S. for the Treatment of Severe Dry Eye
5/20/2013 10:46:40 AM
More...
|
Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes
5/20/2013 10:44:34 AM
More...
|
Sorrento Therapeutics, Inc. Announces Its Approach to Developing Human Antibody Therapeutics Against MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
5/20/2013 9:59:52 AM
More...
|
Immunicum AB Release: Promising Data for Cancer Vaccine INTUVAX™ in the Treatment of Kidney Cancer
5/20/2013 9:51:09 AM
More...
|
|